Antibody against Serum-Hepatitis Antigen
- 21 October 1971
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 285 (17) , 933-938
- https://doi.org/10.1056/nejm197110212851702
Abstract
The passive hemagglutination method was used to evaluate serum-hepatitis (SH, Australia/ HAA) antibody content of conventional, "convalescent" and hyperimmune gamma-globulin preparations. SH antibody was detected at low titer in most batches of conventional gamma globulin (less than 1:2 to 1:64), in contrast to a titer of 1:512,000 in gamma globulin prepared from hemophilic plasma containing known precipitating antibody ("SH immune globulin"). Injection of "SH immune globulin" resulted in the appearance of SH antibody that remained detectable for at least two months in the blood of half of the recipients.Keywords
This publication has 23 references indexed in Scilit:
- Aquisition of hepatitis-associated antigen. Clinical features in young adultsJAMA, 1971
- Hemagglutination Assay for Antigen and Antibody Associated with Viral HepatitisScience, 1970
- Prevention of posttransfusion hepatitis by gamma-globulin. Preliminary reportPublished by American Medical Association (AMA) ,1970
- Serum Hepatitis Antigen (SH): Rapid Detection by High Voltage ImmunoelectroosmophoresisScience, 1970
- Viral hepatitis. New light on an old diseaseJAMA, 1970
- Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndromePublished by American Medical Association (AMA) ,1968
- Liquid nitrogen preservation of red blood cells for transfusionCryobiology, 1968
- γ-Globulin in the Prophylaxis of Posttransfusion HepatitisPublished by American Medical Association (AMA) ,1966
- Gamma-globulin in the prophylaxis of posttransfusion hepatitisJAMA, 1966
- Large Scale Production of Human Plasma FractionsVox Sanguinis, 1962